What is Dystonia?
Dystonia is a neurological movement disorder that causes muscles to contract involuntarily, resulting in twisting and repetitive movements or abnormal postures. It can affect any part of the body, including the arms, legs, neck, face, and vocal cords. Dystonia can be primary, which means it is the sole medical condition present, or secondary, which means it occurs as a result of another underlying medical condition or exposure to certain medications or toxins. The condition can range from mild to severe, and can affect a person’s ability to perform everyday activities. While there is no cure for dystonia, treatment options include medications, botulinum toxin injections, deep brain stimulation, and physical therapy.
In 1984, a report of a patient with Meige syndrome was published. The patient benefited from treatment with 200 mg CBD. Meige syndrome is a form of dystonia affecting the eyelid and facial muscles.
How can CBD help in Dystonia?
There is limited research on the use of CBD (cannabidiol) for dystonia, but some studies suggest that it may have potential as a treatment for this condition.
CBD has been found to have anti-inflammatory and analgesic (pain-relieving) effects, which may help to reduce inflammation and pain associated with dystonia. CBD may also help to regulate the activity of certain neurotransmitters in the brain, which could potentially improve muscle control and reduce muscle spasms.
In addition, CBD has been shown to have anxiolytic (anti-anxiety) effects, which may help to alleviate the psychological symptoms associated with dystonia, such as anxiety and depression.
However, it is important to note that more research is needed to fully understand the effects of CBD on dystonia, and to determine its safety and efficacy as a treatment for this condition. It is important to consult with a healthcare professional before using CBD or any other complementary or alternative therapy for dystonia.
Animal studies on CBD
In mouse studies, the natural cannabinoid CBD attenuated catalepsy, characterised by muscle rigidity and postural stiffness. Catalepsy caused by the antipsychotic drug haloperidol, by L-nitro-N-arginine (L-NOARG) or by the synthetic cannabinoid WIN55,212-2, which acts similarly to THC.
Furthermore, the researchers noted that “these findings indicate that CBD can attenuate catalepsy caused by different mechanisms through activation of 5-HT1A receptors. It therefore suggests that it may be useful in the treatment of disorders of the striatum”. These disorders include Parkinson’s disease, dystonia and dyskinesia.
*Article made by IA